Navigation Links
Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
Date:2/26/2008

op dose of the marketed AII antagonist. Numerous similar studies with other agents that block the renin-angiotensin system support that this result is a strong indication that PS433540 can be expected to lower blood pressure in hypertensive patients. Additional data from the MAD study demonstrated that PS433540 produced statistically significant, dose dependent increases versus placebo in plasma-renin activity, as well as reductions in systolic and diastolic blood pressure in non-hypertensive healthy volunteers.

PS433540 is a dual-acting angiotensin (AII) and endothelin (ET1) receptor antagonist that is being developed as a potential treatment for hypertension and diabetic nephropathy. PS433540, the first and only DARA compound in development, possesses two clinically validated mechanisms of action in a single compound. There is considerable preclinical and initial clinical data suggesting that compared to either agent alone, simultaneously blocking the actions of both AII and ET1 may provide significantly improved treatment options for several cardiovascular diseases.

About Pharmacopeia

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic agreements with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals. For more information please visit
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
8. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
9. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 2014 Raritan Bay Medical Center announces it ... the social media website. Via Twitter, patients and families ... to customer service by using the handle @myrbmc ... accessibility from any device makes it an ideal tool ... patients and community.  Raritan Bay Medical Center has already ...
(Date:9/29/2014)... , Sept. 29, 2014  Diplomat, the ... Stephen Brown has been named chief information ... operations of the information technology department while being ... facilitating internal and external partnerships. Prior ... consultant specializing in the development of technology architectures ...
(Date:9/29/2014)... 29, 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... company focused on the development and commercialization of ... liver diseases and cholesterol gallstones, announced today that ... Itamar Medical Ltd. (TASE: ITMR) ("Itamar Medical"), a ... cleared by the U.S. Food and Drug Administration, ...
Breaking Medicine Technology:@myrbmc: Healthcare Customer Service Support in 140 Characters or Less 2Diplomat names Stephen S. Brown chief information officer 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3
... Mayo ClinicROCHESTER, Minn., March 23 Here are ... Mayo Clinic,s research magazine. You may cite and ... wish. Reprinting is allowed with proper attribution. Please ... policies permit: Visit http://discoverysedge.mayo.edu for subscription ...
... Each year in the United States more than 138,000 people ... cases account for 10 percent of the new total cancer ... of leukemia, the survival rate has not changed in the ... of Foundation Venture Capital Group, LLC, a New Jersey Health ...
Cached Medicine Technology:Discovery's Edge Spring Issue - http://discoverysedge.mayo.edu 2Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments 2
(Date:9/29/2014)... study led by researchers at Brigham and Women,s ... for colorectal cancer screening and surveillance. The study ... than established guidelines support, and these recommendations were ... "Our study shows that a high percentage of ... in use of scarce health care resources with ...
(Date:9/29/2014)... On Friday, September 26, 2014, Narconon Louisiana ... unwanted, unneeded and expired prescription drugs by handing out fliers ... in the local area and noting the closest drop off ... in raising the community’s awareness of the dangers of holding ... or unused drugs in the home is a safety concern ...
(Date:9/29/2014)... September 30, 2014 NAPW ... Professional, as a 2014 Professional Woman of the ... for leadership in medical device consulting. As the largest, ... spanning virtually every industry and profession, the National Association ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:9/29/2014)... City, NY (PRWEB) September 30, 2014 ... OT, NBCOT, CEAS, as a 2014 Professional Woman of ... distinction for leadership in home healthcare. As the largest ... virtually every industry and profession, the National Association of ... over 600,000 members and nearly 300 Local Chapters. , ...
(Date:9/29/2014)... September 30, 2014 NAPW ... 2014 Professional Woman of the Year. Dr. Mondloch is ... and preventative medicine As the largest, most-recognized networking organization ... industry and profession, the National Association of Professional Women ... members and nearly 300 Local Chapters. , “Initially my ...
Breaking Medicine News(10 mins):Health News:Endoscopists recommend frequent colonoscopies, leading to its overuse 2Health News:Narconon Louisiana New Life Retreat Supports the Drug Enforcement Agency’s Ninth Drugs Take Back Day 2Health News:National Association of Professional Women Announces Sandra Lee Bennett, Independent Medical Device Professional, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Carol A. Stormer, Home Health Occupational at LHC GroupTherapist, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Victoria J. Mondloch, M.D., Family Medicine and Women's Health, a 2014 Professional Woman of the Year 2
... ... ... students have an opportunity of a lifetime: write an article about nursing diagnosis for ... , , , , ,The article writing contest is sponsored by Gail Ladwig MSN, ...
... , , MINNEAPOLIS, ... FIT ), a leading provider of integrated employee health and productivity ... present at the Canaccord Adams Healthy Living Conference on Wednesday, September ... at the Renaissance Boston Waterfront Hotel in Boston, MA. , ...
... Alarming comments by new U.S. Global AIDS Coordinator, Ambassador Eric ... 17 Later today, Ambassador Eric Goosby will be sworn in ... Goosby to his new post, and look forward to working with ... and well-being of the world,s vulnerable populations, there are a number ...
... , , , ... , , WASHINGTON, Sept. 17 Last week, ... (D) to release financial documents and correspondence surrounding his Departments using taxpayer ... the Service Employee International Union (SEIU). , , ...
... , Non-profit organizations ... receive funding to help Internally Displaced Persons (IDPs) during the ... NORTH WEST FRONTIER PROVINCE, Pakistan, Sept. 17 The Prem ... medication, cattle and livestock provisions, and fruit plants to aid ...
... , WASHINGTON, Sept. 17 Secretary ... Foundation and Massachusetts General Hospital (MGH) to launch a new ... Stress Disorder and traumatic brain injuries and their families. , ... Veterans Affairs, programs with those of other departments and agencies, ...
Cached Medicine News:Health News:Write your Ticket to Madrid, Spain! 2Health News:Write your Ticket to Madrid, Spain! 3Health News:HealthFitness to Present at the Canaccord Adams Healthy Living Conference 2Health News:Are Obama Administration Policies Undermining Global AIDS and Health Responses? 2Health News:Are Obama Administration Policies Undermining Global AIDS and Health Responses? 3Health News:The Prem Rawat Foundation Makes Two Grants to Provide Relief in Pakistan 2Health News:VA Secretary Helps Launch The Red Sox Foundation-Massachusetts General Hospital Home Base Program 2Health News:VA Secretary Helps Launch The Red Sox Foundation-Massachusetts General Hospital Home Base Program 3Health News:VA Secretary Helps Launch The Red Sox Foundation-Massachusetts General Hospital Home Base Program 4
Standard arthroscope with telescope (4 mm) for large joints....
... Olympus TrueView II telescopes are based on a ... wide field of view allows a tremendous image ... supports easy navigation in the joint with less ... quick lock mechanism for tight and secure camera ...
... is a highly sensitive DR system. It ... and it is designed for most general ... in multiple wall stand and table configurations. ... CXDI-40C efficiently produces detailed patient images with ...
... The original ultrasonic cement ... having an 11-year clinical ... Large array of tool ... femoral applications, cemented and ...
Medicine Products: